Brown DM, Emanuelli A, Bandello F, Barranco JJE, et al. KESTREL and KITE: 52-week results from two Phase III pivotal trials of brolucizumab for diabetic macular edema. Am J Ophthalmol 2022 Jan 13. pii: S0002-9394(22)00006.
PMID: 35038415